Our aim is to study the effect of lacosamide as a preventive treatment of migraine by
assessing the change in the disease duration, attack frequency, and duration, pain intensity
assessed by visual analogic scale, and The Migraine Disability Assessment Test after 90 days
of regular use of 50 mg lacosamide twice daily. in patients diagnosed to have migraine based
upon the International Classification of Headache Disorders (ICHD) 3rd edition.